-
公开(公告)号：EP2552475A1
公开(公告)日：2013-02-06
申请号：EP11713577.2
申请日：2011-03-29
申请人： Allergan, Inc.
CPC分类号： A61K38/4893 , A61K9/0019 , A61K35/74 , C07K14/33 , C12Y304/24069
摘要： Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering from chronic migraine. The injection schedule requires a minimum dose of 155 U using a fixed-site, fixed- dose injection regimen into 31-39 sites across 7 head/nech muscles, namely the frontalis, corrugator, procerus, occipitalis, temporalis, trapezius and cervical paraspinal muscles.
-
公开(公告)号：EP2934571B1
公开(公告)日：2018-05-30
申请号：EP13818897.4
申请日：2013-12-17
申请人： ALLERGAN, INC.
发明人： BRIN, Mitchell F.
CPC分类号： A61K38/4893
摘要： The present invention relates to methods for prophylactic treatment of Herpes recurrence with a Clostridial neurotoxin, such as a botulinum neurotoxin or variant thereof.
-
公开(公告)号：EP2552475B1
公开(公告)日：2016-05-18
申请号：EP11713577.2
申请日：2011-03-29
申请人： ALLERGAN, INC.
CPC分类号： A61K38/4893 , A61K9/0019 , A61K35/74 , C07K14/33 , C12Y304/24069
-
公开(公告)号：EP2934571A1
公开(公告)日：2015-10-28
申请号：EP13818897.4
申请日：2013-12-17
申请人： ALLERGAN, INC.
发明人： BRIN, Mitchell F.
CPC分类号： A61K38/4893
摘要： The present invention relates to methods for prophylactic treatment of Herpes recurrence with a Clostridial neurotoxin, such as a botulinum neurotoxin or variant thereof.
-
-
-
搜索结果
4 条记录 (耗时 0.014 秒)
